多效价载体疫苗免疫大菱鲆效果评价

采用注射与浸泡2种方法,对构建的多效价载体疫苗MVAV6203A-1进行了免疫保护效果和血清效价的研究.结果显示,用多效价载体疫苗注射免疫大菱鲆(Scophthalmus maximus),可同时获得对鳗弧菌(Vibrio anguillarum)和嗜水气单胞菌(Aeromonas hydrophila)的免疫保护效果,免疫相对保护率分别为80.6％和77.0％；用ELISA方法测定血清效价的结果显示,免疫MVAV6203A-1后大菱鲆血清效价最高达到2 048,均值为891,明显高于对照组的97；用多效价载体疫苗浸泡免疫大菱鲆后,对鳗弧菌与嗜水气单胞菌的免疫相对保护率分别为62.2％和11.7％.血清效价分析显示,实验组与对照组的均值均为64.上述结果表明,所构建的疫苗MVAV6203A-1可有效提高大菱鲆对鳗弧菌和嗜水气单胞菌的免疫力,并且免疫和攻毒的途径可能是影响免疫保护效果的因子.本研究旨在为鳗弧菌与嗜水气单胞菌引起的鱼类疾病防治提供技术支撑.

Evaluation of immune effects of a multivalent vector vaccine in turbot, Scophthalmus maximus

Vibrio anguillarum and Aeromonas hydrophila are the primary cause of mortality in marine and fresh water aquaculture.Mortality,due to disease from these two pathogens,has resulted in significant economic loss.Historically,infected fish have been treated with antibiotics,leading to widespread drug resistance among patho-genic bacteria.More recently,a number of vaccines against pathogenic bacteria have been developed and ap-proved for use in aquaculture.Although China has a long history of intensive fish cult...